As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation. Amgen's Lumakras in combination with Vectibix was approved to treat adult patients whose cancer has spread to other parts of the body despite receiving chemotherapy,

"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in colorectal cancer recurrence over placebo, although a mor

Research shows that people with a certain body shape face a higher risk of serious health problems compared to their pear-shaped counterparts, who tend to carry excess weight in the hips, buttocks

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients with mantle cell lymphoma.

Cancer rates for young women are sharply rising, with women under 50 more likely to develop cancer than their male counterparts — by 82%. The rate of cancer for young women “has increased from 51% higher than men in 2002 to 82% higher in 2021,” according to a report i ssued by the American Cancer Society .

Women are now being diagnosed with cancer more often than men in certain age groups, according to a new report from the American Cancer Society. Among adults aged 50-64, cancer rates are slightly higher in women, and women under 50 are almost twice as likely as men in the same age group to receive a cancer diagnosis.

Study of 107,000 participants demonstrates regular aspirin use significantly reduces colorectal cancer risk, especially in individuals with unhealthy lifestyles

Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the American Cancer Society’s annual cancer trends report.

Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in higher costs and worse population-level outcomes.

"Based on data from the eight eligible studies from 2019 to 2023, the committee concludes that compared with never consuming alcohol, moderate alcohol consumption is associated with lower all-cause mortality," the review states. The reviewers rated the conclusion as having "moderate certainty."